Barclays analyst Adrienne Yih upgraded National Vision (EYE) to Overweight from Equal Weight with a price target of $30, up from $17. The firm has a positive view on the company’s transformation efforts. It expects National Vision’s customer focus to dive growth in its total addressable market and ticket. Further, the company should experience wider optometrist reach via remote exams and improved hiring and it has low tariff exposure, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EYE:
- National Vision Holdings Elects Directors at Annual Meeting
- National Vision price target raised to $26 from $22 at BofA
- Strategic Growth Potential and Competitive Advantage Drive Buy Rating for National Vision Holdings
- National Vision price target raised to $19 from $13 at BMO Capital
- National Vision Holdings: Balancing Optimism and Caution Amid Mixed Recovery
